Valuation: LeMaitre Vascular, Inc.

Market Cap 1.93B 1.72B 1.59B 1.44B 2.7B 183B 2.75B 19.17B 7.59B 96.06B 7.25B 7.09B 303B P/E 2026 *
29.4x
P/E 2027 * 26.6x
Enterprise Value 1.69B 1.51B 1.39B 1.26B 2.36B 161B 2.4B 16.79B 6.65B 84.1B 6.35B 6.21B 265B EV / Sales 2026 *
6.11x
EV / Sales 2027 * 5.38x
Free-Float
87.26%
Yield 2026 *
1.18%
Yield 2027 * 1.33%
1 day-1.03%
1 week+4.49%
Current month+2.25%
1 month+3.59%
3 months-11.65%
6 months-25.56%
Current year+4.13%
1 week 81.93
Extreme 81.93
85.62
1 month 78.31
Extreme 78.31
85.62
Current year 78.22
Extreme 78.22
118.01
1 year 78.22
Extreme 78.22
118.01
3 years 44.27
Extreme 44.27
118.01
5 years 38.32
Extreme 38.32
118.01
10 years 18.76
Extreme 18.76
118.01
Manager TitleAgeSince
Chief Executive Officer 61 1992-05-31
Director of Finance/CFO 51 2025-03-09
Director of Finance/CFO 62 1999-12-31
Director TitleAgeSince
Director/Board Member 68 2002-12-31
Chairman 61 2003-12-31
Director/Board Member 61 2016-10-23
Date Insider Type Main position Quantity % Market Cap. Importance
9/3/26 Free

Chairperson

24 0.0001%
9/3/26 Free

Director

6 0.0000%
9/3/26 Free

Chief Operating Officer

14 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%+4.49%-5.34%+80.56% 1.93B
-0.40%-2.34%+17.70%+55.55% 249B
+0.33%+0.64%+3.36%+19.65% 162B
+1.90%+6.00%-17.24%+69.64% 157B
-0.70%+2.93%-54.81%-8.60% 66.22B
+0.15%+4.09%+10.25%+65.85% 52.3B
+0.24%+0.99%-15.49%-12.48% 52.18B
-1.13%+2.85%+17.04%+30.33% 51.34B
-0.47%+0.06%+16.92%+67.38% 48.79B
-0.42%+3.83%+26.19%+87.23% 44.57B
Average -0.15%+2.49%-0.14%+45.51% 88.54B
Weighted average by Cap. +0.14%+1.51%+1.36%+44.11%

Financials

2026 *2027 *
Net sales 277M 247M 228M 207M 387M 26.25B 393M 2.75B 1.09B 13.75B 1.04B 1.02B 43.36B 303M 271M 250M 226M 424M 28.76B 431M 3.01B 1.19B 15.07B 1.14B 1.11B 47.5B
Net income 66.71M 59.58M 55.04M 49.88M 93.31M 6.33B 94.85M 662M 262M 3.32B 250M 245M 10.46B 74.29M 66.34M 61.29M 55.54M 104M 7.05B 106M 737M 292M 3.69B 279M 273M 11.65B
Net Debt -240M -215M -198M -180M -336M -22.83B -342M -2.39B -945M -11.96B -903M -883M -37.71B -300M -268M -248M -225M -420M -28.52B -427M -2.98B -1.18B -14.94B -1.13B -1.1B -47.1B
Projected Income Statement - Annual - LeMaitre Vascular, Inc.
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change Volume
26-10-23 US$84.45 -1.03% 184,574
26-10-22 US$85.33 +1.98% 212,771
26-10-21 US$83.67 +0.32% 216,661
26-10-20 US$83.40 +1.32% 238,025
26-10-19 US$82.31 +1.84% 248,748
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - LeMaitre Vascular, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
84.45USD
Average target price
107.00USD
Spread / Average Target
+26.70%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LeMaitre Vascular, Inc.
  1. Stock Market
  2. Stocks
  3. LMAT Stock